Research Unit 785 : Pathogenesis and Treatment of Fulminant Hepatitis and Liver Carcinogenesis

Page mise à jour le 15/09/2014

INSERM / Paris-Sud Université Joint Research Unit 785 (INSERM U785 for short) is built around the combined skills of research scientists and clinicians with a considerable reputation and expertise in research areas that range from liver transplantation to therapeutic strategies against fulminant hepatitis and primary liver cancer.

Our Research Projets

Technical Facilities

Research Team

Our Supports